Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, the National Institutes of Health, Bethesda, MD, USA.
Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.
Nat Microbiol. 2020 Jun;5(6):796-812. doi: 10.1038/s41564-020-0714-0. Epub 2020 May 4.
Flaviviruses are vector-borne RNA viruses that can emerge unexpectedly in human populations and cause a spectrum of potentially severe diseases including hepatitis, vascular shock syndrome, encephalitis, acute flaccid paralysis, congenital abnormalities and fetal death. This epidemiological pattern has occurred numerous times during the last 70 years, including epidemics of dengue virus and West Nile virus, and the most recent explosive epidemic of Zika virus in the Americas. Flaviviruses are now globally distributed and infect up to 400 million people annually. Of significant concern, outbreaks of other less well-characterized flaviviruses have been reported in humans and animals in different regions of the world. The potential for these viruses to sustain epidemic transmission among humans is poorly understood. In this Review, we discuss the basic biology of flaviviruses, their infectious cycles, the diseases they cause and underlying host immune responses to infection. We describe flaviviruses that represent an established ongoing threat to global health and those that have recently emerged in new populations to cause significant disease. We also provide examples of lesser-known flaviviruses that circulate in restricted areas of the world but have the potential to emerge more broadly in human populations. Finally, we discuss how an understanding of the epidemiology, biology, structure and immunity of flaviviruses can inform the rapid development of countermeasures to treat or prevent human infections as they emerge.
黄病毒是经媒介传播的 RNA 病毒,可在人群中意外出现并引发一系列潜在严重疾病,包括肝炎、血管休克综合征、脑炎、急性弛缓性麻痹、先天畸形和胎儿死亡。在过去的 70 年中,这种流行病学模式已经多次出现,包括登革热病毒和西尼罗河病毒的流行,以及最近美洲发生的寨卡病毒爆炸性流行。黄病毒现在在全球范围内传播,每年感染多达 4 亿人。值得关注的是,在世界不同地区的人类和动物中报告了其他一些特征不那么明显的黄病毒的暴发。这些病毒在人类中维持流行传播的潜力尚未得到充分了解。在这篇综述中,我们讨论了黄病毒的基本生物学、它们的感染周期、它们引起的疾病以及宿主对感染的潜在免疫反应。我们描述了那些对全球健康构成持续威胁的黄病毒,以及那些最近在新人群中出现并导致严重疾病的黄病毒。我们还提供了在世界某些地区传播但有可能在人类中更广泛传播的鲜为人知的黄病毒的例子。最后,我们讨论了如何理解黄病毒的流行病学、生物学、结构和免疫,以便在出现时迅速开发出治疗或预防人类感染的对策。